Nicolet Advisory Services »

Aurinia Pharmaceuticals shares owned by Nicolet Advisory Services

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Nicolet Advisory Services from 13F filings

Historical chart of Nicolet Advisory Services investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Nicolet Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Nicolet Advisory Services

Quarter filed Position value Share count Share price at filing
2023-09-30 $148k 21k 7.19
2023-06-30 $212k 21k 10.12
2023-03-31 $187k 19k 9.86
2022-12-31 $152k 18k 8.33

More positions owned by Nicolet Advisory Services

Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core S&p Ttl Stk (ITOT)
Apple (AAPL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Vanguard Index Fds Mid Cap Etf (VO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Procter & Gamble Company (PG)
Bank First National Corporation (BFC)
Ishares Tr National Mun Etf (MUB)
Jpmorgan Chase & Co Alerian Ml Etn (AMJ)
Microsoft Corporation (MSFT)
Vanguard Scottsdale Fds Long Term Treas (VGLT)

View all positions for Nicolet Advisory Services

Top funds holding Aurinia Pharmaceuticals

NEA Management Company
Goldman Sachs Group
Citadel Advisors
Vanguard Group
Citigroup
Balyasny Asset Management
Caption Management
Jane Street
Tang Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Stifel Financial
GSA Capital Partners
Nordea Investment Management Ab
Barclays

View all funds holding Aurinia Pharmaceuticals